Patents by Inventor Cade Brylee Fox

Cade Brylee Fox has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220007978
    Abstract: Analyte sensors are being increasingly employed for monitoring various analytes in vivo. Analyte sensors may feature enhancements to address signals obtained from interferent species. Some analyte sensors may comprise a working electrode comprising an active area disposed thereon and electrode asperities laser planed therefrom. Some analyte sensors may comprise an interferent-reactant species incorporated therewith. Some analyte sensors may comprise an interferent scrubbing electrode. Combinations of these enhancements may additionally be employed.
    Type: Application
    Filed: June 15, 2021
    Publication date: January 13, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Stephen Oja, Cade Brylee Fox, Lam N. Tran, Zenghe Liu, Benjamin J. Feldman, Udo Hoss, Mark Stephen Yahnke, Tahir S. Khan, Jean-Pierre Babka, Owen Daniel Reynolds
  • Publication number: 20210369155
    Abstract: Analyte sensors featuring an enzyme system comprising diaphorase and a NAD-dependent dehydrogenase may be utilized to detect inhibitors of diaphorase, provided that the transfer of electrons to a working electrode is rate-limiting with respect to the diaphorase. Such analyte sensors may comprise a sensor tail comprising at least a first working electrode, a first active area disposed upon a surface of the first working electrode, and an analyte-permeable membrane overcoating at least the first active area. The enzyme system comprises NAD, reduced NAD, or any combination thereof; a NAD-dependent dehydrogenase, such as NAD-dependent glucose dehydrogenase; and diaphorase. Inhibitors of diaphorase that may be detected include, for example, warfarin, dicoumarol, and similar compounds. A second active area may be present to facilitate detection of an analyte differing from the inhibitor of diaphorase.
    Type: Application
    Filed: May 7, 2021
    Publication date: December 2, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Tianmei Ouyang, Zenghe Liu, Stephen Oja, Ahmed Hisham Wali, Cade Brylee Fox